Vera Therapeutics, Inc. Increase (Decrease) in Other Current Liabilities
Vera Therapeutics, Inc. (VERA) reported Increase (Decrease) in Other Current Liabilities of -$478.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentLiabilities · last filed 2022-03-28
- Vera Therapeutics, Inc. increase (decrease) in other current liabilities for the quarter ending 2020-12-31 was -$295.00K.
- Vera Therapeutics, Inc. increase (decrease) in other current liabilities for the quarter ending 2020-09-30 was -$191.00K.
- Vera Therapeutics, Inc. increase (decrease) in other current liabilities for the quarter ending 2020-06-30 was $1.00K.
- Vera Therapeutics, Inc. increase (decrease) in other current liabilities for the quarter ending 2020-03-31 was $7.00K.
- Vera Therapeutics, Inc. increase (decrease) in other current liabilities for fiscal 2020 was -$478.00K.
| Period end | Increase (Decrease) in Other Current Liabilities 3 month | Increase (Decrease) in Other Current Liabilities 6 month | Increase (Decrease) in Other Current Liabilities 9 month | Increase (Decrease) in Other Current Liabilities 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$295.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$486.00K derived: sum of 2 quarters · filed 2022-03-28 | -$485.00K derived: sum of 3 quarters · filed 2022-03-28 | -$478.00K 10-K · filed 2022-03-28 |
| 2020-09-30 | -$191.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$190.00K derived: sum of 2 quarters · filed 2021-11-10 | -$183.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $8.00K 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $7.00K 10-Q · filed 2021-06-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |